Breaking News
October 16, 2018 - Poor Outcomes for Hispanic Infants With Congenital Heart Dz
October 16, 2018 - Global study finds youngest in class more likely to be diagnosed with ADHD
October 16, 2018 - Researchers sequence two selfish genes in the fungus Neurospora intermedia
October 16, 2018 - Survey results highlight the need for better communication between patients and HCPs about bacterial vaginosis
October 16, 2018 - Researchers develop fibrin-targeting immunotherapy to protect against neurodegeneration
October 16, 2018 - Researchers create open access database on healthy immunity
October 16, 2018 - Rice University chemist wins big award to study small surfaces
October 16, 2018 - Study finds 43% drop in stroke rate
October 16, 2018 - Researchers identify basic relationships of cell cycle and cellular senescence in the placenta
October 16, 2018 - Obesity Doubles Odds for Colon Cancer in Younger Women
October 16, 2018 - Adults with ADHD not constrained in creativity
October 16, 2018 - Raising visibility for people and students with chronic illness and disability
October 16, 2018 - Allele awarded NIH grant to develop nanoantibody therapies for treatment of sepsis
October 16, 2018 - Only 59% of young adults undergoing surgery are fluid responsive
October 16, 2018 - Research points to potential new treatment for hearing loss
October 16, 2018 - MDI Biological Laboratory receives $1.2 million SEPA grant to promote data literacy
October 16, 2018 - Vast majority of dementia cases may arise from spontaneous genetic errors
October 16, 2018 - New project aims to deliver fast, effective treatment for autoimmune rheumatic diseases
October 16, 2018 - Study identifies molecular switch that controls fate of milk-producing breast cells
October 16, 2018 - Research shows diet has little influence on precursor to gout
October 16, 2018 - “Without Dr. Shumway doing his miracle work, three generations would not be here”: A Stanford heart transplant patient’s story
October 16, 2018 - Non-invasive brain stimulation sheds light on neurobiology underlying implicit bias
October 16, 2018 - Researchers demonstrate integrated technique to control production of cell therapeutics
October 16, 2018 - Breast tomosynthesis detects 34% more tumors than traditional mammography
October 16, 2018 - Rhode Island Hospital, Brown receive $800,000 grant to keep up fight against opioid epidemic
October 16, 2018 - UVA partners with health systems in AVIA network’s Medicaid Transformation Project
October 16, 2018 - Trevena Announces Oliceridine FDA Advisory Committee Meeting Outcome
October 16, 2018 - Study reveals early warning signs of heart problems in patients with newly diagnosed lupus
October 16, 2018 - Connecting the dots of Alzheimer’s disease
October 16, 2018 - New publication offers evidence-based content for global breast imaging medical community
October 16, 2018 - ‘EinsteinVision’ that improves hand-eye coordination of surgeons introduced at Harefield Hospital
October 16, 2018 - WRAIR clinical study evaluates safety and immunogenicity of Marburg vaccine
October 16, 2018 - Ketamine can be considered as alternative to opioids for short-term pain control in ED
October 16, 2018 - Endurance exercise training beneficially alters gut microbiota composition
October 15, 2018 - FDA Approves Yutiq (fluocinolone acetonide intravitreal implant) for Chronic Non-Infectious Posterior Segment Uveitis
October 15, 2018 - Birthing Options for Full-Term Pregnancy
October 15, 2018 - Stressed, toxic, zombie cells seen for first time in Alzheimer’s
October 15, 2018 - Concussion researchers study head motion in high school football hits | News Center
October 15, 2018 - Neuropsychiatric symptoms related to earliest stages of Alzheimer’s brain pathology
October 15, 2018 - Neck collar device may help protect the brain of female high school soccer players
October 15, 2018 - Research reveals how the inner ear processes speech
October 15, 2018 - Many parents still skeptical about safety and effectiveness of flu shot, survey finds
October 15, 2018 - Payer Policies May Discourage Non-Pharma Tx for Low Back Pain
October 15, 2018 - Exercise may delay cognitive decline in people with rare Alzheimer’s disease
October 15, 2018 - Researchers modify CRISPR to reorganize genome | News Center
October 15, 2018 - Innovative brain tumor operation set to tailor to patients’ needs
October 15, 2018 - Findings offer new insight into early changes that occur during AD pathology
October 15, 2018 - Neurons regulating reproductive hormone release have different activity in epileptic mice
October 15, 2018 - More parents are concerned about taking babies swimming in public pools
October 15, 2018 - Health Tip: Know the Risk Factors for Lower Back Pain
October 15, 2018 - Study shows cigarillo flavors enhanced by high-intensity sweeteners
October 15, 2018 - Study traces hospital-acquired bloodstream infections to patients’ own bodies | News Center
October 15, 2018 - Abnormal vision in childhood can affect development of brain areas responsible for attention
October 15, 2018 - Study highlights need for increased support for alcohol-related liver disease patients
October 15, 2018 - Color-changing contact lens could help doctors to monitor eye disease medications
October 15, 2018 - Tobacco heating products cause less staining to teeth than conventional cigarettes
October 15, 2018 - Young adults who are obese can expect to lose up to 10 years in life expectancy
October 15, 2018 - Scientists uncover how proteins meet on the cell membrane
October 15, 2018 - Affordable housing with supportive social services for senior citizens can reduce hospital use
October 15, 2018 - Schiller Easy Pulse Saves Lives
October 15, 2018 - The latest ECG device from Schiller
October 15, 2018 - Following a Tissue Sample
October 15, 2018 - Prisoners need drug and alcohol treatments but AA programs aren’t the answer
October 15, 2018 - Andrea Califano and Jordan Orange Elected to National Academy of Medicine
October 15, 2018 - The impending risk of African Swine Fever Virus
October 15, 2018 - Breastfeeding reduces the number of antibiotic-resistant bacteria in infant gut
October 15, 2018 - Researchers develop comprehensive molecular atlas of postnatal mouse heart development
October 15, 2018 - ObsEva SA Presents Clinical Data from Phase III IMPLANT 2 Trial of Nolasiban in IVF at the American Society of Reproductive Medicine (ASRM) Annual Meeting
October 15, 2018 - Engineering teratoma-derived fibroblasts to enhance osteogenesis
October 15, 2018 - Lab study shows effectiveness of potential therapy for treatment-resistant hypothyroidism
October 15, 2018 - JCU study firms up association between diet and depression
October 15, 2018 - Researchers to study the use of CRISPR on human liver on-a-chip platform
October 15, 2018 - Sub-concussive impacts not associated with decline in neurocognitive function
October 15, 2018 - Researchers find potential treatment to halt premature labor and birth
October 15, 2018 - As U.S. suicides rates rise, Hispanics show relative immunity
October 15, 2018 - FDA Issues a Complete Response Letter to Acacia Pharma for Barhemsys
October 15, 2018 - Photoactive bacteria bait may help in fight against MRSA infections
October 15, 2018 - Increasing vigorous exercise reduces risk factors of type 2 diabetes, cardiovascular disease in children
October 15, 2018 - First-of-its-kind study to test a personalized vaccine in cancer patient
October 15, 2018 - Extension trial assesses benefit of switching from flash monitoring to RT-CGM for hypoglycemia
Five addiction experts weigh in on future of opioid crisis. Their forecast: grim

Five addiction experts weigh in on future of opioid crisis. Their forecast: grim

image_pdfDownload PDFimage_print
Credit: CC0 Public Domain

Donald S. Burke has little trouble finding a parallel with the opioid epidemic’s surging death rates and elusive solutions: the early years of AIDS.

Burke led the U.S. Army’s research on HIV/AIDS before and after powerful new medications converted a fatal infection into a chronic disease. He remembers the waves of sickness, barriers of stigma, and frustration of being a doctor with no idea what to do. That, he believes, is roughly where the U.S. is now in the fight against addiction.

“We as a medical profession and we as a society let the AIDS epidemic go from what was a few thousand to what grew to be close to 100 million cases around the planet,” said Burke, dean of the University of Pittsburgh’s Graduate School of Public Health, which conducts extensive research on addiction. “And I think we have to realize that we’re on a trajectory that may get a lot worse before it gets better.”

Just this month, in fact, newly released federal data showed more than 63,000 drug-related deaths in 2016—up 21 percent from the year before and the biggest one-year rise in three decades. Pennsylvania experienced the second-largest jump of all the states.

With substance abuse already a major issue from Philadelphia to the White House this year, the Inquirer interviewed experts in five areas of addiction. Each was asked the same basic questions: Where are we in this crisis? What’s coming next? What has to change?

Perhaps the most optimistic comment, from A. Thomas McLellan, a top drug policymaker in President Barack Obama’s White House, was this: “The medical community is at least aware that you can get addicted if you are in pain.”

—-

Andrew Kolodny

-Co-director of opioid policy research, Brandeis University Heller School for Social Policy and Management

Andrew Kolodny wants to correct the “popular media narrative” that a prescription opioid problem turned into a heroin problem, which turned into a fentanyl problem—and that efforts to check the first worsened the others.

He points to three distinct epidemics:

The smallest is made up of longtime addicts, largely blacks and Latinos in their 50s through 70s. They started on heroin in the 1970s and ’80s, and watched their buddies die off. Fentanyl is killing the survivors.

The middle group, almost entirely white and largely rural and suburban, is in their 20s to 40s. They get the lion’s share of news coverage: young men and women dying in public with needles in their arms. Coroners must investigate their deaths. Many began on prescription painkillers—used recreationally or prescribed by doctors, typically briefly—as far back as the mid-1990s, when Purdue launched OxyContin with extensive marketing to physicians. They managed their addiction by buying costly pills on the street. As their cravings worsened and cheaper heroin became available, they switched. “That switching isn’t new,” Kolodny said. But when dealers began lowering prices by mixing in cheap fentanyl around 2011, switching was more likely to mean dying.

The largest group, in their mid-40s through 80s, is largely invisible and their deaths vastly undercounted. Their regular doctors have prescribed pain pills for years. They never move to heroin. And when they die, of heart disease or an infection, opioids as a contributing factor doesn’t come to mind. “No one wants grandma to have died of an overdose,” Kolodny said.

The differences among the groups show that this is “an addiction epidemic, not a drug abuse problem,” he said.

While more cautious prescribing is preventing some new cases of addiction, the only good solution Kolodny sees for the millions already on opioids is to “build out a new treatment system” at a cost he estimates at $60 billion. “The problem is that the genie is out of the bottle.”

—-

Caroline Johnson

-Acting deputy commissioner, Philadelphia Department of Public Health

“We think that the number of overdoses is continuing to increase,” said Caroline Johnson. But there is “very preliminary” evidence of a “slight leveling off of fatalities,” she said, meaning that deaths this year might rise by just a third or a little more, a dulling of the sharp upward spike that began in late 2016.

That achievement could be due, in part, to the priority the city put on supplying the opioid overdose reversal medication naloxone to community health centers, homeless shelters, rehabs, and SEPTA police. Several hundred residents whose loved ones are addicted have completed two-hour classes in how to administer Narcan, the nasal spray version. The Department of Behavioral Health plans more in the new year.

Johnson co-chaired a subcommittee of Mayor Kenney’s opioids task force that recommended the city consider operating supervised injection sites. They would be “just another tool” in a limited kit, she said.

“That is sort of what Narcan is all about. We aren’t treating addiction, we are just preventing death.”

—-

A. Thomas McLellan

-Former deputy director, Office of National Drug Control Policy

Attitudes have changed dramatically since A. Thomas McLellan began his career at the Philadelphia VA Hospital counseling heroin-addicted soldiers returning from Vietnam.

The public has gotten “much more sophisticated” about addiction, he said. Physical health and mental health are increasingly seen as the responsibility of the same medical system.

He agrees with President Trump’s October declaration of a public health emergency, which provides help ranging from the lifting of budgetary constraints to speeding up contracting. It also empowers state secretaries of health to take similar actions.

“None of that has happened. I’m not sure why. I don’t think it’s political. This is one of the very few issues where everyone agrees it’s important. I really don’t understand it,” McLellan said.

Without action, he said, the recent “exponential” growth in drug deaths will likely continue.

—-

Gary Tuggle

-Special agent in charge, Drug Enforcement Administration’s Philadelphia Division

In a single recent week, Drug Enforcement Administration agents seized 40 kilos of fentanyl bound for Philadelphia. That’s enough to fill tens of millions of glassine bags, reap $40 million for the cartels that shipped them, and kill an unknown number of users who were expecting heroin. (Fentanyl-related deaths doubled nationwide last year.)

Gary Tuggle, who is retiring at the end of the month after 2 { years overseeing DEA’s Philadelphia Division, does not see the busts as a good thing. “We have an insatiable appetite for drugs, both licit and illicit,” he said. The U.S., with 5 percent of the world’s population, consumes 80 percent of the pain medication.

Unlike heroin, which must be grown and processed in lengthy cycles, fentanyl can be easily made using chemicals in a lab, ordered on the dark web, and sent by mail. “Probably a thousand companies in China sell fentanyl,” Tuggle said, and seizures are increasing.

A wave of fentanyl arrived in major cities a dozen years ago and then disappeared. It’s unclear what brought it back, although Tuggle said Mexican cartels had just been hit with major seizures. “Maybe someone figured, ‘We have this demand, we don’t have the product, let’s just use fentanyl.’ “

—-

Donald S. Burke

-Dean, University of Pittsburgh Graduate School of Public Health

A paper that epidemiologist Donald S. Burke co-authored last spring determined that drug fatalities doubled roughly every eight years between 1979 and 2015. The researchers were surprised.

“Through this 37-year interval there have been major fluctuations in the drugs most commonly used, as well as changes in legal prescribing, illicit supply, substance use treatment, and law enforcement. Our observation that this continuous exponential growth pattern began well before the onset of the current opioid epidemic,” they wrote in a preliminary analysis, suggests deeper societal forces may be at work.

The three approaches most commonly cited to prevent opioid overdoses—more naloxone, more medication-assisted treatment, and fewer prescriptions—so far don’t seem to be making much difference,” Burke said.

Modeling by his research team suggests that 150,000 to 200,000 people on pain pills transition to injection drugs every year. “The more people using heroin, the greater the probability that more people will use heroin,” Burke said, “just like the spread of an infectious disease.” If your friends are using, you are more likely to use.

He wonders whether the kind of response used for epidemics like HIV might work: Determine key transition points, like when a painkiller addict is likely to try heroin, find those most at risk, and treat them. That might prevent more people “from moving down the addiction pipeline,” he said.


Explore further:
Fentanyl in more than half of opioid deaths in 10 states

Tagged with:

About author

Related Articles